© BusinessWire
08.01.2026
TEM
LISTED
NASDAQ
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium. The meeting is being held on January 8–10 in San Francisco, California.
“The research Tempus is presenting at...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
INDV
LISTED
NASDAQ
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
News Preview
RICHMOND, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Indivior PLC (Nasdaq: INDV) (“Indivior PLC” or the “Company”) today announced its full-year 2026 financial guidance....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ATAI
LISTED
NASDAQ
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
News Preview
AtaiBeckley provides its outlook for 2026 ahead of attendance at the J.P. Morgan 44th Annual Healthcare Conference...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
08.01.2026
TFX
LISTED
NYSE
Teleflex Announces Leadership Transition
News Preview
Stuart Randle Appointed Interim President and CEO...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
08.01.2026
KDEV
LISTED
STO
Karolinska Development’s Extraordinary General Meeting 2026
News Preview
STOCKHOLM, SWEDEN – January 8, 2026. Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held an Extraordinary General Meeting on January 8, 2026, at which the shareholders resolved as follows....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ORNBV
LISTED
HEL
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
News Preview
ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
BAYN
LISTED
XETR
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
News Preview
Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaboration and global licensing agreement to advance a heart-targeted small interfering RNA (siRNA) therapy. The companies will collaborate to develop a siRNA-based treatment for a form of dila...
Themefolio
Profiler
Peergroup
© EQS Newswire
08.01.2026
EVT
LISTED
XETR
Just – Evotec Biologics erhält Förderung für KI-gestützte Optimierung der Entwicklungsfähigkeit monoklonaler Antikörper zur Verbesserung des bezahlbaren Zugangs
News Preview
Just – Evotec Biologics wird monoklonale Antikörper und andere biologische Modalitäten optimieren
Die Investition ermöglicht in den nächsten drei Jahren zehn neue J.MD™-Projekte zur molekularen Optimierung; darin inbegriffen, aber nicht beschränkt auf: verbesserte Titer, Pharmakokinetik, Immunogenität und Stabilität
Hamburg, 0......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.01.2026
EVT
LISTED
XETR
Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
News Preview
Just – Evotec Biologics will optimize monoclonal antibodies (“mAbs”) and other biologic modalities
Investment enables ten new J.MD™ projects encompassing molecular optimization including, but not limited to: improved titer, pharmacokinetics, immunogenicity, and stability, over the next three years
Hamburg, Germany, January 08,......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
08.01.2026
EVT
LISTED
XETR
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
News Preview
Just - Evotec Biologics will optimize monoclonal antibodies ("mAbs") and other biologic modalitiesInvestment enables ten new J.MD™ projects encompassing molecular optimization including, but not limited to: improved titer, pharmacokinetics, immunogenicity, and stability, over the next three years HAMBURG, DE / ACCESS Newswire / Janu...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
SOBI
LISTED
STO
Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data
News Preview
STOCKHOLM, Jan. 7, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with observed improvement in organ dysfunction and survival.
Based on the observed data from this research collabor...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
SOBI
LISTED
STO
Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data
News Preview
STOCKHOLM, Jan. 7, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with observed improvement in organ dysfunction and survival.
Based on the observed data from this research collabor...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
07.01.2026
GNFT
LISTED
EURONEXT
GENFIT Announces 2026 Financial Calendar
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its provisional financial calendar for 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS7 JANUARY 2026 at 16:30 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
GMAB
LISTED
CPH
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence
News Preview
Media ReleaseCOPENHAGEN, Denmark; January 07, 2026...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
ACET
LISTED
NASDAQ
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
News Preview
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate updates and highlighted upcoming milestones for 2026.
“Heading into 2026, we are proud of the strong execution across our pipeline. Since reporting...
Themefolio
Profiler
Peergroup
© ActuNews
07.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma Announces the Appointment of Julien Veys as Deputy Chief Executive Officer
News Preview
Lyon, France – January 7, 2026, 8:00 a.m. CET – The Board of Directors of THX Pharma (Theranexus), a pharmaceutical company specializing in rare neurological diseases, today announces the appointment of Julien Veys as Deputy Chief Executive Officer. This appointment is part of the continued development of THX Pharma and the implementati...
Themefolio
Profiler
Peergroup
© ActuNews
07.01.2026
ALTHX
LISTED
EURONEXT
THERANEXUS : THX Pharma annonce la nomination de Julien Veys au poste de Directeur général adjoint
News Preview
Lyon, France – 7 janvier 2026, 8h CET – Le Conseil d'administration de THX Pharma (Theranexus), société pharmaceutique spécialisée dans les maladies neurologiques rares, annonce aujourd'hui la nomination de Julien Veys au poste de Directeur général adjoint. Cette nomination s'inscrit...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
BAVA
LISTED
CPH
Bavarian Nordic Launches Planned Share Buy-Back Program
News Preview
COPENHAGEN, Denmark, January 7, 2026 – Bavarian Nordic A/S (OMX: BAVA) today launches the first tranche of the share buy-back program announced on December 2, 2025, under which the Company intends to repurchase own shares for up to DKK 500 million during 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2026
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS7 January 2026 at 08.30 EET ...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.01.2026
ANAB
LISTED
NASDAQ
Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan 13, 202...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.01.2026
GNFT
LISTED
EURONEXT
GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 6, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that G1090N – a small molecule and the Company’s lead investigational drug candidate for Ac...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2026
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2026
AUTL
LISTED
NASDAQ
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell ShuttleTM Platform
News Preview
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first Integrated Development and Manufacturing Organization (IDMO), today announced that Autolus will assess the feasibility of Cellares’ Cell Shuttle pla...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2026
TEM
LISTED
NASDAQ
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, California.
Tempus Founder and CEO Eric Lefkofsky will deliver a presentation, followed by a live Q&A session,...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2026
ZLAB
LISTED
NASDAQ
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has approved the supplemental New Drug Application (sNDA) for AUGTYRO™ (repotrectinib) for the treatment of adult patients with solid tumors that harbor a neurotrophic tyrosine receptor kinase (NTRK) gene fusion. The approval is...
Themefolio
Profiler
Peergroup
© PR Newswire
06.01.2026
BIOA B
LISTED
STO
BLA for subcutaneous formulation of Leqembi® accepted in China
News Preview
STOCKHOLM, Jan. 6, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of Leqembi (lecanemab) for treatment of early Alzheimer's disease has been accepted by the National Medical Products...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.01.2026
FAGR
LISTED
EURONEXT
Fagron announces the completion of Purifarma
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 January 2026 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
INSP
LISTED
NYSE
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Com...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
BAYN
LISTED
XETR
Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference
News Preview
Bayer will participate in the 44th J.P. Morgan Healthcare Conference 2026 taking place from January 12–15, 2026 in San Francisco. Stefan Oelrich, Member of the Board of Management, Bayer AG, and President of Bayer’s Pharmaceuticals Division, will present updates on the company’s pharmaceutical growth strategy and pipeline advancements across its p...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
ZEAL
LISTED
CPH
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
News Preview
Press release – No. 1 / 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
ASND
LISTED
NASDAQ
Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
COPENHAGEN, Denmark, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 44th Annual J.P. Morgan Healthcare Conference and provide a business update on Monday, January 12, 2026, at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time in San Francisco, California....
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
ZLAB
LISTED
NASDAQ
Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, at 3:00 p.m. PST / 6:00 p.m. EST.
A live webcast of the presentation will be available on the Investor Relations page of Zai Lab’s we...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
NUTX
LISTED
NASDAQ
NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO
News Preview
HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that the Compan...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2026
KPTI
LISTED
NASDAQ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEWTON, Mass., Jan. 2, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 1,533 restricted stock units (RSUs) to two newly-hired employees. These RSU awards were granted as of December 31, 2025 (the "...
Themefolio
Profiler
Peergroup
© BusinessWire
02.01.2026
INSP
LISTED
NYSE
Deadline Soon: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming January 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusi...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
02.01.2026
EVT
LISTED
XETR
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
News Preview
Creation of new Executive Vice President role integrating Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment HAMBURG, DE / ACCESS Newswire / January 2, 2026 / Evotec SE (NASDAQ:EVO; Frankfurt Prime Standard:EVT) today announced the appointment of Dr. Sarah Fakih as Executive Vice President, Head...
Themefolio
Profiler
Peergroup
© EQS Newswire
01.01.2026
EVT
LISTED
XETR
Evotec ernennt Dr. Sarah Fakih als EVP, Leiterin Global Communications und Investor Relations
News Preview
Evotec ernennt Dr. Sarah Fakih als EVP, Leiterin Global Communications und Investor Relations
Neue Executive Vice President-Rolle vereint Global Communications und Investor Relations zur Stärkung strategischer Botschaften und einer klaren Stakeholder-Ansprache
Hamburg, 1. Januar 2026:
Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) gab heute......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.01.2026
EVT
LISTED
XETR
Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
News Preview
Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Creation of new Executive Vice President role integrating Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment
Hamburg, Germany, January 1, 2026:
Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) toda......
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ZEAL
LISTED
CPH
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
News Preview
Company announcement – No. 27 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
OGI
LISTED
NASDAQ
Organigram Extends Innovation Investment with Phylos
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share1, today announced the expansion of its innovation investment in Phylos Bioscience Inc. (“Phylos”), securing Organigram’s position as a leader in seed-based cannabis genetics. Through an amended loan and product agreement,...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS31 December 2025 at 13.00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
INSP
LISTED
NYSE
INSP INVESTORS: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Inspire Medical Systems, Inc.
News Preview
The law firm of Kirby McInerney LLP reminds Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) investors of the January 5, 2026 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Inspire securities between August 6, 2024 through August 4, 2025 (“the Class Period”).
Follow...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ATAI
LISTED
NASDAQ
AtaiBeckley Completes Redomiciliation to the United States
News Preview
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments, today announced the completion of the redomiciliation of the parent company o...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS30 December 2025 at 14:00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
GMAB
LISTED
CPH
Genmab Portfolio Prioritization Update
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44th Annual J.P. Morg...
Themefolio
Profiler
Peergroup
© BusinessWire
26.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.12.2025
IBAB
LISTED
EURONEXT
IBA signs contract for a three-room Proteus®PLUS solution to be installed at the Seoul St. Mary’s Hospital
News Preview
Louvain-La-Neuve, Belgium, December 26, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract with the Catholic University of Korea, Seoul St. Mary’s Hospital, one of the...
Themefolio
Profiler
Peergroup
© PR Newswire
24.12.2025
CU6
LISTED
ASX
Co-PSMA abstract accepted for oral presentation at EAU Annual Congress 2026
News Preview
SYDNEY, Dec. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the acceptance of an abstract on the Co-PSMA (NCT06907641)[1] Investigato...
Themefolio
Profiler
Peergroup
© BusinessWire
24.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© PR Newswire
23.12.2025
CTXR
LISTED
NASDAQ
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
News Preview
Subsidiary, Citius Oncology, launches cancer immunotherapy, LYMPHIR™, in the U.S. in December 2025CRANFORD, N.J., Dec. 23, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today...
Themefolio
Profiler
Peergroup
© PR Newswire
23.12.2025
CTXR
LISTED
NASDAQ
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
News Preview
Cancer Immunotherapy, LYMPHIR™, launched in the U.S. in December 2025Completed $36 million in strategic financings, of which $18 million was via private placement and concurrent registered direct offering on December 10, 2025, to strengthen cash position and support continued commercialization of LYMPHIRCRANFORD, N.J., Dec. 23, 2025 /PRNewswire/ -...
Themefolio
Profiler
Peergroup
© BusinessWire
23.12.2025
LIVN
LISTED
NASDAQ
LivaNova to Present at J.P. Morgan Healthcare Conference in January
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco. Vladimir Makatsaria, Chief Executive Officer of LivaNova, and Alex Shvartsburg, Chief Financial Officer, will participate in a fireside chat on Wed., Jan. 14, 2026, at 1:30...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.12.2025
FYB
LISTED
XETR
FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner
News Preview
Press Release // December 23, 2025
FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner
FDA approves Biologics License Application (BLA) for additional ranibizumab biosimilar under the trade name Nufymco®
Zydus becomes commercialization partner for Nufymco® ......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.12.2025
FYB
LISTED
XETR
FDA erteilt Zulassung für weiteres austauschbares Ranibizumab-Biosimilar Nufymco® – Stärkung der US-Präsenz mit Zydus als Vermarktungspartner
News Preview
Pressemitteilung // 23. Dezember 2025
FDA erteilt Zulassung für weiteres austauschbares Ranibizumab-Biosimilar Nufymco® – Stärkung der US-Präsenz mit Zydus als Vermarktungspartner
FDA genehmigt Biologics License Application (BLA) für weiteres Ranibizumab-Biosimilar unter dem Handelsnamen Nufymco®
Zydus wird Kommerzialisierungspartner für Nu......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.12.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS23 December 2025 at 16.00 EET ...
Themefolio
Profiler
Peergroup
© BusinessWire
23.12.2025
ZLAB
LISTED
NASDAQ
Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) approved the New Drug Application (NDA) for COBENFY® (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. COBENFY is the first schizophrenia therapy with a novel mechanism of action approved in over 70...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
